US singer Katy Perry has won a ruling shielding communications with lawyers from 2009 in a trade mark dispute with Australian fashion designer Katie Perry.
US chemical company Quaker Chemical is seeking special leave from the High Court to appeal a Full Court judgment that found its patents for quickly detecting high pressure fluid injection injuries on site were not novel because the company had disclosed them in public prior to applying for registration with IP Australia.
US financial services giant State Street has appealed its loss in a lawsuit brought against Maurice Blackburn over the law firm’s use of a replica of the famous Fearless Girl statue.
Singapore-based telecommunications giant Singtel, which owns Optus, has launched a copyright lawsuit seeking discovery from a former vice-president who jumped ship to Telstra.
For intellectual property barrister David Larish, one of the most pivotal moments in his career had nothing to do with working on a case.
Law firm Thomson Geer has bolstered the ranks of its media team with the recruitment of News Corp senior litigation counsel Marlia Saunders to its Sydney office.
Billionaire Clive Palmer has agreed to pay part of Universal Music’s costs on an indemnity basis, after a judge found he infringed substantial parts of the copyright for Twister Sister’s rock anthem ‘We’re Not Gonna Take It’ and ordered him to pay $1.5 million in damages.
The Full Federal Court has upheld US biotech company Sequenom’s patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic’s argument that the patent merely described a way to extract incorporeal genetic information.
A judge has overturned a ruling from the Australian Patent Office that shortened the amount of time available to companies under patent term extensions, saying a “liberal rather than literal” reading was needed to achieve the extension regime’s goals of compensating holders of drug patents for the lengthy time required to obtain regulatory approval to market their drugs.
Switzerland-based Biogen has sued generic drug maker MSN Laboratories for allegedly threatening to infringe the patent for its top-selling oral MS drug Tecfidera.